Masha Zhdanava
Education
M.A., economics, Dalhousie University; B.A., economics, European Humanities University
Summary of Experience
Ms. Zhdanava specializes in the application of statistical methods to the field of health economics and outcomes research. Her expertise includes burden of illness analyses, treatment effectiveness and treatment patterns analyses, disease epidemiology studies, and cost models. Ms. Zhdanava has worked with a variety of data, including health insurance claims, electronic medical records, and data collected from chart reviews. Her research in a wide range of therapeutic areas, including depression, schizophrenia, asthma, psoriasis, and oncology, has been presented at conferences and published in peer-reviewed journals such as the Journal of Clinical Psychiatry, the Journal of Affective Disorders, BMC Psychiatry, Allergy & Asthma Proceedings, Clinical Therapeutics, Current Medical Research and Opinion, and the Journal of Medical Economics.
-
Economic Burden Associated With Nasal Polyposis Recurrence Among Commercially Insured Patients in the United States
Otolaryngology–Head and Neck Surgery, 2023
2023Zhdanava M, Ndife B, Pilon D, Rossi C, Vermette-Laforme M, Lefebvre P, Suh JD
-
Ischemic Stroke and Systemic Embolism among One-and-Done Direct Oral Anticoagulant Users with Non-Valvular Atrial Fibrillation
Advances in Therapy, 2023
2023Alberts M, Zhdanava M, Pilon D, Caron-Lapointe G, Lefebvre P, Bookhart B, Kharat A
-
Treatment Patterns, Healthcare Utilization, and Costs of Patients with Treatment-Resistant Depression Initiated on Esketamine Intranasal Spray and Covered by Us Commercial Health Plans
Journal of Medical Economics, 2023
2023Joshi K, Pilon D, Shah A, Holiday C, Karkare S, Zhdanava M
-
Venous Thromboembolism Recurrence among One-and-Done Direct Oral Anticoagulant Users: A Retrospective Longitudinal Study
International Journal of Clinical Pharmacy, 2023
2023Alberts M, Zhdanava M, Pilon D, Caron-Lapointe G, Lefebvre P, Bookhart B, Kharat A
-
Esketamine Nasal Spray for Major Depressive Disorder with Acute Suicidal Ideation or Behavior: Description of Treatment Access, Utilization, and Claims-Based Outcomes in the United States
Journal of Medical Economics, 2023
2023Zhdanava M, Teeple A, Pilon D, Shah A, Caron-Lapointe G, Joshi K
-
Treatment Persistence among Bio-Naïve Patients with Crohn's Disease Initiated on Ustekinumab or Adalimumab
Current Medical Research and Opinion, 2023
2023Zhdanava M, Ding Z, Manceur AM, Muser E, Lefebvre P, Holiday C, Lafeuille MH, Pilon D
-
Economic Burden of Commercially Insured Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior in the United States
Journal of Clinical Psychiatry, 2022
2022Pilon D, Neslusan C, Zhdanava M, Sheehan J, Joshi K, Morrison L, Rossi C, Lefebvre P, Greenberg P
-
Characteristics of Real-World Commercially Insured Patients With Treatment-Resistant Depression Initiated on Esketamine Nasal Spray or Conventional Therapies in the United States
Clinical Therapeutics, 2022
2022Karkare S, Zhdanava M, Pilon D, Nash AI, Morrison L, Shah A, Lefebvre P, Joshi K
-
Understanding the Health System Conditions Affecting the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia in Clinical Practice: A US Healthcare Provider Survey
Neuropsychiatric Disease and Treatment, 2022
2022Zhdanava M, Starr HL, Lefebvre P, Totev TI, Shah A, Sheng K, Pilon D
-
Excess healthcare resource utilization and healthcare costs among privately and publicly insured patients with major depressive disorder and acute suicidal ideation or behavior in the United States
Journal of Affective Disorders, 2022
2022Zhdanava M, Voelker J, Pilon D, Joshi K, Morrison L, Sheehan JJ, Vermette-Laforme M, Lefebvre P, Citrome L
-
Cluster Analysis of Care Pathways in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the USA
PharmacoEconomics (2021) 39:707–720
2021Zhdanava M, Voelker J, Pilon D, Cornwall T, Morrison L, Vermette‑Laforme M, Lefebvre P, Nash A, Joshi K, Neslusan C
-
The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States
Journal of Clinical Psychiatry, 2021
2021Zhdanava M, Pilon D, Ghelerter I, Chow W, Joshi K, Lefebvre P, Sheehan JJ
-
Special Issue of PharmacoEconomics on Major Depressive Disorders
PharmacoEconomics (2021) 39:617
2021 -
Prevalence of Pre-existing Conditions Relevant for Adverse Events and Potential Drug-Drug Interactions Associated with Augmentation Therapies Among Patients with Treatment-Resistant Depression
Advances in Therapy, 2021
2021Zhdanava M, Karkare S, Pilon D, Joshi K, Rossi C, Morrison L, Sheehan J, Lefebvre P, Lopena O, Citrome L
-
Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics
Journal of Managed Care & Specialty Pharmacy, 2021
2021Pilon D, Patel C, Lafeuille MH, Zhdanava M, Lin D, Côté-Sergent A, Rossi C, Lefebvre P, Joshi K
-
Prevalence, incidence and economic burden of schizophrenia among Medicaid beneficiaries
Current Medical Research and Opinion, 2021
2021Pilon D, Patel C, Lafeuille MH, Zhdanava M, Lin D, Côté-Sergent A, Rossi C, Joshi K, Lefebvre P
-
Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy
Journal of Medical Economics, 2021
2021Pilon D, Karkare S, Zhdanava M, Sheehan JJ, Côté-Sergent A, Shah A, Lopena OJ, Lefebvre P, Joshi K, Citrome L
-
Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions
Journal of Managed Care & Specialty Pharmacy, 2020
2020Zhdanava M, Kuvadia H, Joshi K, Daly E, Pilon D, Rossi C, Morrison L, Lefebvre P, Nelson C
-
Prevalence of Potential Drug-Drug Interactions and Pre-existing Conditions for Adverse Events in Augmentation Therapies Among Patients With Treatment-resistant Depression
Psych Congress, 2020
2020Zhdanava M, Karkare S, Pilon D, Joshi K, Rossi C, Morrison L, Sheehan J, Lefebvre P, Lopena O, Citrome L
-
October 23, 2023
-
March 2, 2023
-
April 12, 2022
-
June 14, 2021
-
June 10, 2021
-
June 8, 2021
-
January 21, 2021